Advanced search×

[Secondary osteoporosis UPDATE. The etiology, prevalence, and characteristics of secondary osteoporosis].

Toru T Yamaguchi and Toshitsugu T Sugimoto

Clin Calcium 20(5):637-44 (2010) PMID 20445274

Secondary osteoporosis is caused by various disorders, metabolic derangements, and drug administration, whose elimination as a cause for osteoporosis is necessary before establishing the diagnosis of primary osteoporosis. The underlying diseases or conditions are diversified, including those related to endocrine, nutrition, rheumatism, immobility, medicine, hematology, and congenital one. Among them, osteoporosis induced by steroid administration and that accompanied by diabetes mellitus are most frequently observed. They exhibit high fracture risks based on deteriorated bone quality rather than reduced bone mass.

DOI: CliCa1005637644
Version: za2963e q8za2 q8zb5 q8zc4 q8zd6 q8ze1 q8zfc q8zg8

Similar articles you may find interesting…

  1. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey.
    Paul Arora, Priya Vasa, and Alaa Badawi

    CMAJ (2013) PMID 23649413

    The prevalence of chronic kidney disease during the period 2007-2009 was 12.5%, representing about 3 million Canadian adults. The estimated prevalence of stage 3-5 disease was 3.1% (0.73 million adults) and albuminuria 10.3% (2.4 million adults). The prevalence of diabetes, hypertension and hypertrig...
  2. Itraconazole : an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections.
    Jodi Lestner and William W Hope

    Expert Opin Drug Metab Toxicol (2013) PMID 23641752

    Fungal infections are a major source of global morbidity and mortality. Itraconazole is a triazole antifungal agent that is widely used for the prevention and treatment of fungal infection. While newer antifungal agents are now available, itraconazole is an orally bioavailable agent with broad-spect...
  3. Vitamin D and systemic lupus erythematosus: an update.
    Chi Chiu Mok

    Expert Rev Clin Immunol 9(5):453-63 (2013) PMID 23634739

    Vitamin D is a steroid hormone that, in addition to its actions on calcium and bone metabolism, exhibits a plethora of regulatory effects on growth, proliferation, apoptosis and function of the cells of the immune system that are relevant to the pathophysiology of systemic lupus ery...